Press Releases

Press Releases

Date Title and Summary Additional Formats
Jan 06, 2021 Catalyst Pharmaceuticals Announces Strategic Plan for Product Portfolio Expansion for Long-Term Success and Provides Corporate Update
Company to Expand R&D Focus for Pipeline Growth to include Earlier Stage Programs and Validated Technology Platforms FirdapseĀ® 2020 Net Revenues Estimate of approximately $118 Million ; about 16% Increase From 2019 Ended 2020 with Estimated $140 Million in Cash and Investments Company Highlights